- Raised $75M funding round led by Medicxi, Aug 2023
- Raised $57M funding round led by Pontifax, Sep 2020
- Raised $6M funding round, Apr 2018
About
Fore Biotherapeutics is a precision oncology company using functional genomics to pioneer treatments that improve the lives of patients with rare cancers. Using its functional genomics platform, the company is hyper-targeting therapies for unaddressed tumor mutations to benefit patients with few therapeutic alternatives. Its mission is to provide one-to-one matching between patients and new treatments tailored to them while providing broad access with speed and quality.
Fore’s proprietary functional genomics capabilities, called Foresight, are elucidating disease biology to deliver hyper-targeted treatments to patients with unaddressed tumor mutations. Newly identified driver mutations are retested through Foresight for their response to different compounds. Compounds that reduce oncogenic signaling pathway activity are flagged as potential drug candidates, generating a range of potential new therapeutic applications.
Funding history · 7 rounds · $153.5M total
Q&A
- What is Fore Biotherapeutics' primary focus?
- Fore Biotherapeutics is a precision oncology company that uses functional genomics to develop treatments for patients with rare cancers.
- When was Fore Biotherapeutics founded?
- Fore Biotherapeutics was founded in June 2011.
- How much funding has Fore Biotherapeutics raised in total?
- Fore Biotherapeutics has raised a total of $153,500,000.
- When was Fore Biotherapeutics' most recent funding round and who were the lead investors?
- Fore Biotherapeutics' most recent funding round was in August 2023, with Medicxi and SR One as lead investors.
- What is the employee count for Fore Biotherapeutics?
- Fore Biotherapeutics has 51–200 employees.
- What is the name of Fore Biotherapeutics' proprietary functional genomics platform?
- Fore Biotherapeutics' proprietary functional genomics platform is called Foresight.
- Which investors participated in Fore Biotherapeutics' September 2020 funding round?
- The September 2020 funding round for Fore Biotherapeutics included Pontifax.
- Where is Fore Biotherapeutics headquartered?
- Fore Biotherapeutics is headquartered in Jerusalem, Israel, with an additional office in Philadelphia, USA.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fore.bio |
|---|---|
| linkedin.com/company/18062584 |
Identifiers & details
| Former names | NovellusDx |
|---|---|
| Founded | 2011-6 |
| Employees (exact) | 51 |
| Offices | Philadelphia |
Radar intelligence
GitHub
| Top repos | Suiter-Final-Project, docker.github.io |
|---|
Web history (Wayback)
| Domain | fore.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 7 |
|---|